Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova’s Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes ...

One of Leveson’s suggestions is to remove the right to choose a jury trial in cases where the maximum sentence does not ...

Cookie choices We use cookies and similar technologies to provide our services and to measure and improve your experience. If you choose ‘Accept’, the online marketing you see about ITV will be more ...

Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on ...

Plans to reduce the number of jury trials and create a new type of crown court where trials are heard by judges were unveiled ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the 48 mg, multiple ascending dose ...

A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...

LOS ANGELES, CA / ACCESS Newswire / July 9, 2025 / HRC Fertility is proud to announce its participation in a groundbreaking ...

Origin is opening access to advertisers interested in measuring deduplicated cross-media reach and frequency across linear TV ...